Literature DB >> 14569207

Evaluation and management of pulmonary hypertension in systemic sclerosis.

Ioana R Preston1, Nicholas S Hill.   

Abstract

This review summarizes the most recent studies on pulmonary hypertension related to systemic sclerosis, emphasizing new insights into pathophysiology, identification of new markers, and advances in the diagnosis and treatment of this complication that greatly worsens the prognosis of patients with systemic sclerosis.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14569207     DOI： 10.1097/00002281-200311000-00013

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN： 1040-8711            Impact factor:   5.006


  2 in total

1.  Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis.

Authors:  Predrag Ostojić; Nemanja Damjanov
Journal:  Clin Rheumatol       Date:  2006-04-28       Impact factor: 2.980

2.  Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.

Authors:  Andriana I Papaioannou; Epaminondas Zakynthinos; Konstantinos Kostikas; Theodoros Kiropoulos; Angela Koutsokera; Athanasios Ziogas; Athanasios Koutroumpas; Lazaros Sakkas; Konstantinos I Gourgoulianis; Zoe D Daniil
Journal:  BMC Pulm Med       Date:  2009-05-09       Impact factor: 3.317
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.